quinidine has been researched along with methyldopa in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (51.43) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (17.14) | 29.6817 |
2010's | 11 (31.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Fishel, B; Herzberg, M; Wiener, MH | 1 |
Flaherty, T; Geary, CG | 1 |
Lees, KR; Rubin, PC | 1 |
Kumar, KL; Reuler, JB | 1 |
Tabor, PA | 1 |
Hattori, N; Kobayashi, K; Matsushita, E; Morimoto, H; Tanaka, N | 1 |
Almeyda, J; Levantine, A | 2 |
Davies, NE; Harrison, CE | 1 |
Fischer, JT | 1 |
Pisciotta, AV | 1 |
Leibetseder, F | 1 |
Hueber, EF | 1 |
Hancock, EW | 1 |
Greenblatt, DJ; Lloyd, BL | 1 |
Schreiber, AD | 1 |
BREST, AN; MOYER, JH | 1 |
Terada, H | 1 |
8 review(s) available for quinidine and methyldopa
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug-induced fever.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Body Temperature Regulation; Drug Hypersensitivity; Fever; Humans; Methyldopa; Phenytoin; Procainamide; Quinidine | 1986 |
[Toxic hepatitis induced by cardiovascular agents].
Topics: Adult; Aged; Ajmaline; Anti-Arrhythmia Agents; Antihypertensive Agents; Cardiovascular Agents; Chemical and Drug Induced Liver Injury; Diuretics; Humans; Male; Methyldopa; Procaine; Quinidine; Warfarin | 1985 |
Cutaneous reactions to cardiovascular drugs.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Clonidine; Debrisoquin; Digitalis Glycosides; Drug Eruptions; Ethacrynic Acid; Furosemide; Guanethidine; Humans; Hydralazine; Mercury; Methyldopa; Nitroglycerin; Pentaerythritol Tetranitrate; Procainamide; Quinidine; Thiazines | 1973 |
Drug reactions. XVI. Lichenoid drug eruptions.
Topics: Aminosalicylic Acids; Aniline Compounds; Arsphenamine; Chlorothiazide; Chlorpropamide; Dermatitis, Exfoliative; Gold; Humans; Hydrochlorothiazide; Lichen Planus; Methyldopa; Phenothiazines; Phenylbutazone; Quinacrine; Quinidine; Tetracycline; Thiazoles | 1971 |
[Drug-induced immune hemolytic anemias].
Topics: Adsorption; Anemia, Hemolytic; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Antigen-Antibody Complex; Autoantibodies; Benzenesulfonates; Cell Membrane; Coombs Test; Drug-Related Side Effects and Adverse Reactions; Erythrocytes; Haptens; Humans; Methyldopa; Molecular Weight; Penicillins; Phenylbutazone; Quinidine; Surface Properties; Tranquilizing Agents | 1973 |
Idiosyncratic hematologic reactions to drugs.
Topics: Agranulocytosis; Anemia, Aplastic; Anemia, Hemolytic; Anemia, Hypochromic; Anemia, Macrocytic; Aspirin; Bone Marrow; Bone Marrow Cells; Bone Marrow Examination; Cell Differentiation; Cell Division; Cephalothin; Chloramphenicol; Coombs Test; Drug Hypersensitivity; Erythrocytes; Humans; Methyldopa; Penicillins; Phenytoin; Purpura, Thrombocytopenic; Quinidine | 1974 |
[Drug-induced hemolytic anemia].
Topics: Anemia, Hemolytic; Anti-Bacterial Agents; Antigen-Antibody Complex; Antiviral Agents; Autoantibodies; Diagnosis, Differential; Glucosephosphate Dehydrogenase Deficiency; Haptens; Hemolytic-Uremic Syndrome; Humans; Methyldopa; Penicillins; Procainamide; Proton Pump Inhibitors; Purpura, Thrombotic Thrombocytopenic; Quinidine; Ribavirin | 2007 |
27 other study(ies) available for quinidine and methyldopa
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Hepatic microsomal enzyme induction and its evaluation in a clinical laboratory.
Topics: Adult; Aged; Diazepam; Digoxin; Enzyme Induction; Female; Furosemide; gamma-Glutamyltransferase; Glucaric Acid; Humans; Male; Methyldopa; Microsomes, Liver; Middle Aged; Quinidine | 1977 |
Autoimmune haemolytic anaemia.
Topics: Adult; Agglutinins; Anemia, Hemolytic, Autoimmune; Antibody Specificity; Autoantibodies; Child; Cold Temperature; Complement System Proteins; Erythrocytes; Humans; Immunoglobulin G; Immunoglobulin M; Methyldopa; Middle Aged; Penicillins; Pneumonia, Mycoplasma; Quinidine | 1979 |
Treatment of cardiovascular diseases.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Antihypertensive Agents; Digoxin; Female; Humans; Lidocaine; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular; Quinidine | 1987 |
Drug fever.
Topics: Allopurinol; Anti-Bacterial Agents; Body Temperature Regulation; Drug Hypersensitivity; Fever; Humans; Interleukin-1; Isoniazid; Methyldopa; Phenytoin; Procainamide; Quinidine | 1986 |
Unusual reactions to common cardiovascular drugs.
Topics: Aged; Cardiovascular Diseases; Digitalis Glycosides; Drug Eruptions; Drug Hypersensitivity; Female; Gynecomastia; Humans; Male; Methyldopa; Middle Aged; Procainamide; Purpura; Quinidine | 1970 |
Drug allergy. II.
Topics: Aged; Anemia, Hemolytic; Antigen-Antibody Reactions; Blood Platelets; Chlorpromazine; Dermatitis, Contact; Drug Hypersensitivity; Female; Hemolysis; Histamine H1 Antagonists; Humans; Hypersensitivity, Delayed; Leukopenia; Methyldopa; Middle Aged; Penicillins; Photosensitivity Disorders; Protein Binding; Purpura; Quinidine; Sulfonamides | 1971 |
[Toxic and drug-induced hemolytic anemias].
Topics: Aminosalicylic Acids; Anemia, Hemolytic; Anti-Bacterial Agents; Bacterial Infections; Hemolysis; Humans; Hydantoins; Lead Poisoning; Methyldopa; Phenacetin; Quinidine | 1971 |
[On combined therapy of hypertension and heart insufficiency. Advantages and disadvantages].
Topics: Arrhythmias, Cardiac; Chlorthalidone; Digitoxin; Drug Synergism; Heart Function Tests; Humans; Hypertension; Hypokalemia; Methyldopa; Myocardial Infarction; Quinidine; Reserpine | 1966 |
Bigeminal rhythm on multiple cardiac drug therapy.
Topics: Arrhythmias, Cardiac; Cardiovascular Agents; Digoxin; Drug Therapy, Combination; Electrocardiography; Furosemide; Humans; Hydrochlorothiazide; Male; Methyldopa; Middle Aged; Nitroglycerin; Potassium Chloride; Quinidine | 1984 |
Neuropsychiatric sequelae of pharmacotherapy of cardiac arrhythmias and hypertension.
Topics: Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Brain; Drug Interactions; Guanethidine; Humans; Hydralazine; Hypertension; Lidocaine; Methyldopa; Procainamide; Psychotropic Drugs; Quinidine; Seizures | 1981 |
Autoimmune hemolytic anemia.
Topics: Adolescent; Adrenal Cortex Hormones; Anemia, Hemolytic, Autoimmune; Antigen-Antibody Reactions; Autoantibodies; Child; Child, Preschool; Complement Pathway, Classical; Complement System Proteins; Erythrocytes; Female; Haptens; Humans; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Infant; Male; Methyldopa; Penicillins; Quinidine; Splenectomy | 1980 |
DRUG THERAPY OF HYPERTENSION.
Topics: Alkaloids; Antihypertensive Agents; Chlorothiazide; Diuretics; Ganglionic Blockers; Guanethidine; Hydralazine; Hypertension; Methyldopa; Monoamine Oxidase Inhibitors; Norepinephrine; Pargyline; Quinidine; Rauwolfia; Veratrum; Veratrum Alkaloids | 1964 |